This site is intended for Healthcare professionals only.

Unichem Labs gets EIR from USFDA for Goa facility

Unichem Labs gets EIR from USFDA for Goa facility

New Delhi: Drug firm Unichem Laboratories has received Establishment Inspection Report (EIR) from the US health regulatorfor the company’s plant at Goa.

The company’s formulations manufacturing facility at Goa has received an EIR from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing on Friday.

This receipt indicates successful closure of the inspection and queries raised during the audit, it added.

The inspection that was carried out between March 14-20, 2017 has now been closed by the regulator, the company said.

READ  USFDA rejects filing for Celgene MS drug, shares fall


Source: PTI
0 comment(s) on Unichem Labs gets EIR from USFDA for Goa facility

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted